CNS Pharmaceuticals's total assets for Q3 2023 were $2.33M, a decrease of -63.92% from the previous quarter. CNSP total liabilities were $4.07M for the fiscal quarter, a 1.79% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.